AddLife acquires V-Tech AB & Esthe-Tech AB

17 March 2016

12:00

Regulatory

Today, AddLife signed an agreement to acquire all the shares in the companies V-Tech AB and Esthe-Tech AB. On acquisition, the companies will be incorporated into the Medtech Business Area.

V-Tech markets and sells a product range focusing on surgery, in particular on vascular surgery. It also represents several leading suppliers in its speciality area. Its customers operate mainly in public healthcare in Sweden, Norway and Finland. Esthe-Tech markets and sells specialist products for aesthetic and plastic surgery, its product range is marketed primarily to authorised practitioners in private healthcare. The two companies have 11 employees and combined sales of around SEK 50 million.

The acquisitions represent an expansion above all in the area of vascular surgery, strengthening AddLife’s position in an attractive segment of the Nordic market.

Ownership will become effective on 1 April 2016. The acquisitions are expected to have a marginally positive effect on AddLife’s earnings per share.

Stockholm, 17 March 2016

AddLife AB (publ)

For further information, please contact
Kristina Willgård, VD, AddLife AB, +46-705 10 12 23
Artur Aira, COO, AddLife AB, +46-705 50 00 90

AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region. AddLife has about 425 employees in some 25 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 1.7 billion. Addlife shares are listed on NASDAQ Stockholm.

This information is disclosed in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act and/or the regulations of NASDAQ Stockholm. The information was provided for publication at 12.00 noon (CET) on 17 March 2016.

Release (pdf)